Table of Contents Author Guidelines Submit a Manuscript
International Journal of Otolaryngology
Volume 2010, Article ID 424161, 8 pages
http://dx.doi.org/10.1155/2010/424161
Research Article

Decreased Risk of Squamous Cell Carcinoma of the Head and Neck in Users of Nonsteroidal Anti-Inflammatory Drugs

1Department of Otolaryngology Head and Neck Surgery, Georgetown University Hospital, Washington, DC 20007, USA
2Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA
3Department of Biostatistics, Georgetown University Medical Center, Washington, DC 20057, USA

Received 11 November 2009; Revised 17 March 2010; Accepted 27 March 2010

Academic Editor: Patrick James Bradley

Copyright © 2010 Neda Ahmadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Google Scholar · View at Scopus
  2. E. M. Sturgis, Q. Wei, and M. R. Spitz, “Descriptive epidemiology and risk factors for head and neck cancer,” Seminars in Oncology, vol. 31, no. 6, pp. 726–733, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA: Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Franceschi, R. Talamini, S. Barra et al., “Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in Northern Italy,” Cancer Research, vol. 50, no. 20, pp. 6502–6507, 1990. View at Google Scholar
  5. A. Mashberg, P. Boffetta, R. Winkelman, and L. Garfinkel, “Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. Veterans,” Cancer, vol. 72, no. 4, pp. 1369–1375, 1993. View at Google Scholar · View at Scopus
  6. M. L. Gillison, W. M. Koch, R. B. Capone et al., “Evidence for a causal association between human papillomavirus and a subset of head and neck cancers,” Journal of the National Cancer Institute, vol. 92, no. 9, pp. 709–720, 2000. View at Google Scholar · View at Scopus
  7. F. R. Khuri, E. S. Kim, J. Jack Lee et al., “The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial,” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 8, pp. 823–829, 2001. View at Google Scholar · View at Scopus
  8. W. R. Panje, “Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor,” Archives of Otolaryngology, vol. 107, no. 11, pp. 658–663, 1981. View at Google Scholar · View at Scopus
  9. R. Sjodahl, “Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects,” The American Journal of Medicine, vol. 110, no. 1, pp. 66S–69S, 2001. View at Google Scholar
  10. D. P. Cronin-Fenton, L. Pedersen, T. L. Lash, S. Friis, J. A. Baron, and S. H. Toft, “Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study,” Breast Cancer Research, vol. 12, p. R15, 2010. View at Google Scholar
  11. M. J. Thun, M. M. Namboodiri, E. E. Calle, W. D. Flanders, and C. W. Heath Jr., “Aspirin use and risk of fatal cancer,” Cancer Research, vol. 53, no. 6, pp. 1322–1327, 1993. View at Google Scholar
  12. A. Garidou, A. Tzonou, L. Lipworth, L. B. Signorello, V. Kalapothaki, and D. Trichopoulos, “Life-style factors and medical, conditions in relation to esophageal cancer by histologic type in a low-risk population,” International Journal of Cancer, vol. 68, no. 3, pp. 295–299, 1996. View at Google Scholar · View at Scopus
  13. C. Bosetti, S. Gallus, and C. L. Vecchia, “Aspirin and cancer risk: an updated quantitative review to 2005,” Cancer Causes and Control, vol. 17, no. 7, pp. 871–888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. González-Pérez, L. A. García Rodríguez, and R. López-Ridaura, “Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a metal-analysis,” BMC Cancer, vol. 3, p. 28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Baron, B. F. Cole, R. S. Sandler et al., “A randomized trial of aspirin to prevent colorectal adenomas,” The New England Journal of Medicine, vol. 348, no. 10, pp. 891–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. B. F. Cole, R. F. Logan, S. Halabi et al., “Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials,” Journal of the National Cancer Institute, vol. 101, no. 4, pp. 256–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-F. Liu, G. G. Jamieson, T.-C. Wu, G.-J. Zhu, and P. A. Drew, “A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia,” Annals of Surgical Oncology, vol. 16, no. 5, pp. 1397–1402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. C. Abnet, N. D. Freedman, F. Kamangar, M. F. Leitzmann, A. R. Hollenbeck, and A. Schatzkin, “Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis,” British Journal of Cancer, vol. 100, no. 3, pp. 551–557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. A. Gatenby, J. R. Ramus, C. P. Caygill, M. C. Winslet, and A. Watson, “Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort,” European Journal of Cancer Prevention, vol. 18, no. 5, pp. 381–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Bosetti, R. Talamini, S. Franceschi, E. Negri, W. Garavello, and C. La Vecchia, “Aspirin use and cancers of the upper aerodigestive tract,” British Journal of Cancer, vol. 88, no. 5, pp. 672–674, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Jayaprakash, N. R. Rigual, K. B. Moysich et al., “Chemoprevention of head and neck cancer with aspirin: a case-control study,” Archives of Otolaryngology—Head & Neck Surgery, vol. 132, no. 11, pp. 1231–1236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. B. Gillespie, M. W. Moody, F.-S. Lee et al., “Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users,” Archives of Otolaryngology—Head & Neck Surgery, vol. 133, no. 1, pp. 28–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Waldron, M. E. Hughes, and T. L. Brooks, “Marriage protection and marriage selection-prospective evidence for reciprocal effects of marital status and health,” Social Science & Medicine, vol. 43, no. 1, pp. 113–123, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. N. J. Johnson, E. Backlund, P. D. Sorlie, and C. A. Loveless, “Marital status and mortality: the national longitudinal mortality study,” Annals of Epidemiology, vol. 10, no. 4, pp. 224–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. R. S. Greenberg, M. J. Haber, W. S. Clark et al., “The relation of socioeconomic status to oral and pharyngeal cancer,” Epidemiology, vol. 2, no. 3, pp. 194–200, 2001. View at Google Scholar
  26. F.-M. Fang, H.-C. Chiu, W.-R. Kuo et al., “Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 4, pp. 959–968, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. G. Vartanian, A. L. Carvalho, J. Toyota, I. S. Giacometti Kowalski, and L. P. Kowalski, “Socioeconomic effects of and risk factors for disability in long-term survivors of head and neck cancer,” Archives of Otolaryngology—Head & Neck Surgery, vol. 132, no. 1, pp. 32–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Franceschi, L. D. Maso, F. Levi, E. Conti, R. Talamini, and C. L. Vecchia, “Leanness as early marker of cancer of the oral cavity and pharynx,” Annals of Oncology, vol. 12, no. 3, pp. 331–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Goodin and S. J. Shiff, “NSAIDs for the chemoprevention of oral cancer: promise or pessimism? Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia,” Clinical Cancer Research, vol. 10, no. 5, pp. 1561–1564, 2004. View at Google Scholar
  30. G. Chan, J. O. Boyle, E. K. Yang et al., “Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck,” Cancer Research, vol. 59, no. 5, pp. 991–994, 1999. View at Google Scholar · View at Scopus
  31. T. T. K. Jung, N. T. Berlinger, and S. K. Juhn, “Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study,” Laryngoscope, vol. 95, no. 3, pp. 307–312, 1985. View at Google Scholar · View at Scopus
  32. C. H. Snyderman, M. Milanovich, R. L. Wagner, and J. T. Johnson, “Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients,” Head and Neck, vol. 17, no. 2, pp. 108–113, 1995. View at Google Scholar · View at Scopus
  33. K. A. Scioscia, C. H. Snyderman, R. Rueger et al., “Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs,” American Journal of Otolaryngology, vol. 18, no. 1, pp. 1–8, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Gallo, A. Franchi, L. Magnelli et al., “Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis,” Neoplasia, vol. 3, no. 1, pp. 53–61, 2001. View at Google Scholar · View at Scopus
  35. J. H. Botha, K. M. Robinson, N. Ramchurren, K. Reddi, and R. J. Norman, “Human esophageal carcinoma cell lines: prostaglandin production, biological properties, and behavior in nude mice,” Journal of the National Cancer Institute, vol. 76, no. 6, pp. 1053–1056, 1986. View at Google Scholar · View at Scopus
  36. S. Murono, T. Yoshizaki, H. Sato, H. Takeshita, M. Furukawa, and J. S. Pagano, “Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression,” Cancer Research, vol. 60, no. 9, pp. 2555–2561, 2000. View at Google Scholar · View at Scopus
  37. T. Tanaka, A. Nishikawa, Y. Mori, Y. Morishita, and H. Mori, “Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats,” Cancer Letters, vol. 48, no. 3, pp. 177–182, 1989. View at Publisher · View at Google Scholar · View at Scopus
  38. D. S. Cross, J. L. Platt, S. K. Juhn, F. H. Bach, and G. L. Adams, “Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck,” Archives of Otolaryngology—Head & Neck Surgery, vol. 118, no. 5, pp. 526–528, 1992. View at Google Scholar · View at Scopus
  39. C. H. Snyderman, M. M. Abbas, R. Wagner, and F. D'Amico, “Inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitor increases leukotriene B4 production,” Archives of Otolaryngology—Head & Neck Surgery, vol. 121, no. 9, pp. 1017–1020, 1995. View at Google Scholar · View at Scopus
  40. S. M. Fischer, G. D. Mills, and T. J. Slaga, “Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism,” Carcinogenesis, vol. 3, no. 11, pp. 1243–1245, 1982. View at Google Scholar · View at Scopus
  41. K. A. Scioscia, C. H. Snyderman, F. D'Amico, S. Comsa, R. Rueger, and B. Light, “Effects of arachidonic acid metabolites in a murine model of squamous cell carcinoma,” Head & Neck, vol. 22, no. 2, pp. 149–155, 2000. View at Google Scholar
  42. F. G. Ondrey, S. K. Juhn, and G. L. Adams, “Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition,” Laryngoscope, vol. 106, no. 2 I, pp. 129–134, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. A. O. Berg, J. D. Allan, P. S. Frame et al., “Aspirin for the primary prevention of cardiovascular events: recommendation and rationale,” Annals of Internal Medicine, vol. 136, no. 2, pp. 157–160, 2002. View at Google Scholar · View at Scopus